In summary, these findings suggest that CPSF6 enhances the Warburg effect and angiogenesis, leading to cancer progression via c-Myc mediated by the HK, PD-L1, and VEGF networks, with its siRNA synergistic effect with sorafenib as a molecular target in liver cancer therapy (Figure 9). The gene discussed is MYC; the disease is cancer.